Jaypirca Matches Imbruvica's Effectiveness for CLL, With Hints of Long-Term BenefitByJason M BroderickDecember 7th 2025
Older Patients With DLBCL May Benefit From First-Line Epkinly Plus R-mini-CHOPByKristie L. KahlDecember 7th 2025